TuHURA BIOSCIENCES, INC./NV Shares Outstanding (Cover Page)
TuHURA BIOSCIENCES, INC./NV (HURA) had Shares Outstanding (Cover Page) of 63.73 million shares as of 2026-08-11, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-11: Entity Common Stock, Shares Outstanding 63.73M shares.
- 2026-05-12: Entity Common Stock, Shares Outstanding 63.68M shares.
- 2026-04-24: Entity Common Stock, Shares Outstanding 63.68M shares.
- 2026-03-23: Entity Common Stock, Shares Outstanding 63.58M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-11 | 63.73M shares 10-Q · filed 2026-08-14 |
| 2026-05-12 | 63.68M shares 10-Q · filed 2026-05-15 |
| 2026-04-24 | 63.68M shares 10-K/A · filed 2026-04-30 |
| 2026-03-23 | 63.58M shares 10-K · filed 2026-03-31 |
| 2025-11-11 | 51.26M shares 10-Q · filed 2025-11-14 |
| 2025-08-11 | 50.05M shares 10-Q · filed 2025-08-14 |
| 2025-05-12 | 43.68M shares 10-Q · filed 2025-05-15 |
| 2025-03-31 | 43.68M shares 10-K · filed 2025-03-31 |
| 2024-11-14 | 42.28B shares 10-Q · filed 2024-11-14 |
| 2024-10-07 | 55.66B shares 10-K · filed 2024-10-07 |
| 2024-05-13 | 55.30B shares 10-Q · filed 2024-05-14 |
| 2024-02-12 | 39.04B shares 10-Q · filed 2024-02-14 |
| 2023-11-13 | 3.39B shares 10-Q · filed 2023-11-13 |
| 2023-09-14 | 1.75M shares 10-K · filed 2023-09-18 |
| 2023-05-10 | 1.69M shares 10-Q · filed 2023-05-11 |
| 2023-02-13 | 1.68M shares 10-Q · filed 2023-02-14 |
| 2022-11-08 | 80.81M shares 10-Q · filed 2022-11-09 |
| 2022-09-26 | 80.81M shares 10-K · filed 2022-09-27 |
| 2022-05-11 | 65.53M shares 10-Q · filed 2022-05-13 |
| 2022-02-09 | 49.06M shares 10-Q · filed 2022-02-11 |
| 2021-11-11 | 48.54M shares 10-Q · filed 2021-11-15 |
| 2021-09-28 | 43.17M shares 10-K · filed 2021-09-28 |
| 2021-05-11 | 32.62M shares 10-Q · filed 2021-05-13 |
| 2021-02-10 | 30.63M shares 10-Q · filed 2021-02-12 |
| 2020-11-09 | 24.66M shares 10-Q · filed 2020-11-12 |
| 2020-09-15 | 23.54M shares 10-K · filed 2020-09-18 |
| 2020-05-12 | 11.43M shares 10-Q · filed 2020-05-13 |
| 2020-02-12 | 11.41M shares 10-Q · filed 2020-02-13 |
| 2019-11-12 | 11.40M shares 10-Q · filed 2019-11-13 |
| 2019-09-06 | 11.39M shares 10-K · filed 2019-09-09 |
| 2019-05-14 | 2.65M shares 10-Q · filed 2019-05-14 |
| 2019-02-11 | 25.59M shares 10-Q · filed 2019-02-11 |
| 2018-11-13 | 22.56M shares 10-Q · filed 2018-11-13 |
| 2018-09-21 | 22.41M shares 10-K · filed 2018-09-24 |
| 2018-05-14 | 22.01M shares 10-Q · filed 2018-05-15 |
| 2018-02-13 | 21.93M shares 10-Q · filed 2018-02-14 |
| 2017-11-08 | 21.60M shares 10-Q · filed 2017-11-09 |
| 2017-09-27 | 21.55M shares 10-K · filed 2017-09-27 |
| 2017-05-12 | 13.46M shares 10-Q · filed 2017-05-12 |
| 2017-02-09 | 10.60M shares 10-Q · filed 2017-02-10 |
| 2016-11-10 | 10.42M shares 10-Q · filed 2016-11-10 |
| 2016-09-12 | 10.32M shares 10-K · filed 2016-09-13 |
| 2016-05-12 | 40.25M shares 10-Q · filed 2016-05-12 |
| 2016-02-12 | 40.25M shares 10-Q · filed 2016-02-12 |
| 2015-11-16 | 39.48M shares 10-Q · filed 2015-11-16 |
| 2015-08-26 | 39.48M shares 10-K · filed 2015-11-16 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-15 |
| 2015-02-10 | 34.85M shares 10-Q · filed 2015-02-12 |
| 2014-11-07 | 33.91M shares 10-Q · filed 2014-11-07 |
| 2014-08-27 | 30.11M shares 10-K · filed 2014-08-28 |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-15 |
| 2014-03-07 | 24.43M shares 10-K · filed 2014-03-10 |
| 2013-11-08 | 24.00M shares 10-Q · filed 2013-11-08 |
| 2013-05-15 | 22.42M shares 10-Q · filed 2013-08-12 |
| 2012-12-31 | 3.94M shares 10-Q · filed 2013-01-18 |
| 2012-09-30 | 3.94M shares 10-Q/A · filed 2012-12-20 |
| 2012-06-30 | 5.95M shares 10-K/A · filed 2012-12-20 |
| 2012-03-31 | 5.95M shares 10-Q/A · filed 2012-06-05 |
| 2011-12-31 | 3.94M shares 10-Q · filed 2012-02-07 |
| 2011-09-30 | 5.95M shares 10-Q · filed 2011-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |